News
The FDA cleared the investigational new drug application of IDE849, a potential first-in-class DLL3-targeted antibody-drug ...
A company product sold by Trader Joe's, the Sesame Miso Salad with Salmon, has been recalled affecting 18 states after some ...
A salsa product recalled in April due to the possible presence of wood has now been issued a Class II risk classification by the FDA.
A California-based company has announced a recall of salsa products that may be contaminated with small wood particles.
The mislabeling of allergens is a leading cause of food recalls in the U.S., and can have serious or life-threatening implications for those with allergies.
The FDA issued an RTF for sBLA of nogapendekin alfa plus BCG for BCG-unresponsive NMIBC papillary disease, following prior ...
16h
Medical Device Network on MSNSS Innovations to submit de novo classification request for surgical robotic systemThe company stated that it has installed 37 systems, which have been used in over 750 multi-specialty surgeries.
ISB 2001 is a tri-specific antibody therapeutic for targeting BCMA and CD38 on myeloma cells, as well as CD3 on T cells.
The FDA has approved Johnson & Johnson’s drug Imaavy for the treatment of generalized myasthenia gravis, a chronic autoimmune neuromuscular disorder. The approval covers adults and pediatric patients ...
A recall of seafood burgers has been updated to the highest risk by the U.S. Food and Drug Administration. Connecticut-based company Caraluzzi’s Markets initiated the recall in April because its ...
SS Innovations International, Inc. (the "Company” or "SS Innovations”) (Nasdaq: SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and ...
IGI, Inc., a global, fully integrated clinical-stage biotechnology company focused on developing multispecifics™ in oncology, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results